Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alferon LDO in Asymptomatic HIV+ Subjects
NCT00215852Phase 2Terminated
- Sponsor
- AIM ImmunoTech
- Start
- Jul 2005
- Primary completion
- Apr 2009
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa-n3 in human immunodeficiency virus infection (HIV), sponsored by AIM ImmunoTech. Started Jul 2005; status: terminated.
02
Drugs
interferon alfa-n3
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00215852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215852.